from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0699/-

LFCtreatmentdescriptionclass of inhibitor

0.415

Amikacinug/mL Amikacintranslation

0.323

Cap5-10ug/mL Capreomycintranslation

0.093

Rox10-50 ug/mL Roxithromycintranslation

-0.036

SM2-5 ug/mL Streptomycintranslation

1.479

Tet5-10 ug/mL Tetracyclinetranslation

1.597

Rif0.2-5ug/mL Rifampicintranscription

0.176

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.141

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.537

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.070

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.043

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.705

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.130

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.379

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

2.830

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.455

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.581

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.022

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.673

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.108

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.772

KCN5-20 ug/mL Potassium cyaniderespiration

0.145

NaN30.2-2 mM Sodium aziderespiration

-0.293

Nigericin50 uM Nigericinrespiration

0.391

TRC10-150 ug/mL Triclosanrespiration

0.519

TRZ10-25 ug/mL Thioridazinerespiration

0.622

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.489

menadione6-10 ug/mL Menadionerespiration

0.361

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.143

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.158

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.289

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.068

NRP_1Non-replicating persistence stage 1dosRassociated

-0.642

Amp0.2mg/mL AmpicillincellWall

-0.312

Cephalexin20-100 ug/mL CephalexincellWall

-0.069

Cerulenin0.32-5 ug/mL CerulenincellWall

0.634

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.134

EMB10-20 ug/mL EthambutolcellWall

-0.283

Eta12-40 ug/mL EthionamidecellWall

0.174

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.342

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.063

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.088

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.478

BZA0.12 mg/mL BenzamidearomaticAmides

-0.182

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.711

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.837

H2O24 mM hydrogen peroxideDNAdamaging

-0.043

Levo10 ug/mL LevofloxacinDNAdamaging

0.388

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.020

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.456

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.219

UVUV-irradiationDNAdamaging

-0.037

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.067

Antimycin12.5-50 ug/mL Antimycin A?

-0.185

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.073

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.177

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.288

PA8240.2-2 ug/mL PA-824?

0.210

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.224

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.193

Verapamil50 uM Verapamil?

0.104

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.176

methoxatin10-20 ug/mL Methoxatin?